Research Paper Volume 14, Issue 15 pp 6169—6186
A signature constructed with mitophagy-related genes to predict the prognosis and therapy response for breast cancer
Figure 4. Validation of the 13-gene signature in GSE20685. (A and B) Survival time and status of each breast cancer (BC) sample based on the risk score. (C) Survival analysis between two risk subgroups. (D) Receiver operating characteristic (ROC) curve of the 13-gene signature. (E) Principal component analysis (PCA) of the 13-gene signature.